Cleared Traditional

K231814 - ValvuloPro Valvuloplasty Balloon Catheter (FDA 510(k) Clearance)

Oct 2023
Decision
113d
Days
Class 2
Risk

K231814 is an FDA 510(k) clearance for the ValvuloPro Valvuloplasty Balloon Catheter. This device is classified as a Balloon Aortic Valvuloplasty (Class II - Special Controls, product code OZT).

Submitted by Dongguan TT Medical, Inc. (Dongguan, CN). The FDA issued a Cleared decision on October 12, 2023, 113 days after receiving the submission on June 21, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1255. A Balloon Aortic Valvuloplasty Catheter Is Indicated For Balloon Valvuloplasty Of The Aortic Valve..

Submission Details

510(k) Number K231814 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 2023
Decision Date October 12, 2023
Days to Decision 113 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code OZT — Balloon Aortic Valvuloplasty
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1255
Definition A Balloon Aortic Valvuloplasty Catheter Is Indicated For Balloon Valvuloplasty Of The Aortic Valve.